Skip to main content
Cardio Diagnostics Holdings, Inc. logo

Cardio Diagnostics Holdings, Inc. — Investor Relations & Filings

Ticker · CDIO ISIN · US56168P2039 LEI · 529900E3UWQ6LHYRCK14 US Professional, scientific and technical activities
Filings indexed 273 across all filing types
Latest filing 2026-02-19 Regulatory Filings
Country US United States of America
Listing US CDIO

About Cardio Diagnostics Holdings, Inc.

http://www.cardiodiagnosticsinc.com

Cardio Diagnostics Holdings, Inc. is a biotechnology company specializing in the development and commercialization of clinical tests for cardiovascular disease. The company leverages a proprietary platform that integrates artificial intelligence with epigenetics and genetics to enable early detection and prevention of heart disease. Its primary products are blood-based tests, including Epi+Gen CHD and PrecisionCHD™, which assess a patient's risk for coronary heart disease. These diagnostic tools analyze an individual's unique genetic and epigenetic markers to provide personalized insights, aiming to make cardiovascular care more precise and accessible for clinicians and patients.

Recent filings

Filing Released Lang Actions
8-K - CARDIO DIAGNOSTICS HOLDINGS, INC. (0001870144) (Filer)
Regulatory Filings
2026-02-19 English
PRIMARY DOCUMENT
Director's Dealing
2026-01-06 English
PRIMARY DOCUMENT
Director's Dealing
2026-01-06 English
PRIMARY DOCUMENT
Director's Dealing
2026-01-06 English
PRIMARY DOCUMENT
Director's Dealing
2026-01-06 English
FORM 10-Q
Interim / Quarterly Report Q3 2025
2025-11-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.